The technical hurdle the researchers faced is deceptively simple to state. Adult organs are large, measured in millimeters to centimeters, while the cells that compose them are measured in micrometers. Conventional light microscopes cannot resolve every nucleus throughout a thick, intact organ, and sectioning the organ into slices destroys the spatial relationships that matter for understanding growth. Expansion microscopy, first developed in the mid-2010s, offered a way out by physically swelling tissue samples so that their features spread apart and become resolvable under standard optics. But applying the technique to an entire adult organ, rather than a thin slice, required a substantial engineering effort to make the method uniform, robust, and compatible with fluorescent reporters that label specific cell types.

The team’s solution was an integrated pipeline that combines tissue clearing, gel embedding, isotropic expansion, and high-speed light-sheet fluorescence imaging. They worked with transgenic zebrafish whose hepatocyte nuclei carry fluorescent tags, so every liver cell could be individually identified in the final images. After expansion and imaging, computational analysis stitched the data into a complete three-dimensional atlas of the liver, in which each hepatocyte could be located, counted, and measured. The result is a genuine whole-organ census: an intact adult zebrafish liver, spanning roughly five millimeters in thickness, was found to contain an average of 1,265,206 hepatocytes. That number, obtained by direct observation rather than extrapolation, sets a new benchmark for quantitative organ biology.

With the census in hand, the researchers turned to the central question of growth dynamics. They imaged livers at multiple stages across the post-embryonic period, from juvenile fish through fully mature adults, and charted how hepatocyte numbers changed over time. The pattern they found was strikingly non-linear. Rather than growing steadily in proportion to the body, the liver’s cell population increased by a remarkable 538-fold, and much of that increase was packed into a temporally concentrated burst of proliferation. In other words, the liver does not simply scale up with the rest of the animal; it follows its own growth schedule, with an intense phase of cell addition that is decoupled from overall body growth.

This decoupling is more than a curiosity. It suggests that organs possess intrinsic growth programs that operate on their own timelines, potentially governed by internal cues such as local signaling gradients, mechanical stress, or metabolic demand rather than by systemic growth factors alone. For developmental biologists, the finding reframes post-embryonic organ growth as an active, staged process rather than a passive consequence of the animal getting bigger. It also raises new questions about how a growing liver maintains its architecture, its blood supply, and its bile duct network while its cell population expands by more than two orders of magnitude in a relatively short window.

Counting cells, however, only tells part of the story. The deeper question is which cells are responsible for the growth. Are new hepatocytes generated broadly, with most existing cells dividing a little, or are they the descendants of a small subset of progenitors that divide a lot? To find out, the team integrated lineage tracing with their expansion microscopy workflow. In lineage tracing, a small number of cells are permanently labeled with a heritable fluorescent marker, and all of their descendants carry that same label. By combining this approach with whole-organ imaging, the researchers could trace clone territories, the spatial footprints of individual founding cells, across the entire adult liver.

The answer was unambiguous: liver growth is driven by a few hepatocytes undergoing drastic clonal expansion at the whole-organ scale. Instead of a democratic process in which every cell contributes equally, the growing liver is dominated by a small number of lineages whose progeny multiply extensively and come to occupy large territories within the organ. This clonal organization echoes principles seen in other self-renewing tissues, such as the intestinal epithelium and the blood system, where a limited pool of highly proliferative cells sustains tissue mass. Seeing the same logic play out across an entire intact vertebrate organ, rather than in a two-dimensional section, gives the observation a new level of rigor and visual force.

The clonal picture also has implications for how we think about liver disease and regeneration. The mammalian liver is famous for its ability to regrow after injury, and hepatocellular carcinoma is often discussed in terms of clonal expansion of mutated cells. If normal liver growth in zebrafish is naturally driven by a few dominant clones, then the boundary between physiological growth and pathological expansion may be governed by regulatory mechanisms that keep clonal proliferation in check. Understanding those mechanisms in a transparent, genetically tractable vertebrate could illuminate what goes wrong when clonal control fails in human disease.

The researchers did not stop at cell numbers and clones. They also asked how the liver’s three-dimensional shape emerges during growth, and whether shape and cell number are controlled by the same or different mechanisms. Their target was the extracellular matrix, specifically laminins, a family of proteins that form a structural scaffold around tissues and are known to influence cell behavior. When the team disrupted laminin function, they observed a striking dissociation: the liver’s overall shaping was perturbed even as total cell number increases continued. This decoupling suggests that tissue architecture and cell proliferation are regulated independently, with the extracellular matrix acting as an architectural control layer that is at least partly separate from the growth control layer. For bioengineers trying to grow organs in the lab, the lesson is that building the right structure requires more than making enough cells; the scaffold matters on its own terms.

Perhaps the most exciting aspect of the study is its generality. The authors showed that WAO-ExM is not limited to healthy livers. They applied the workflow to diseased livers, where it could resolve pathological changes at single-cell resolution across the whole organ, and to other adult zebrafish organs, including the heart and the pancreas. In each case, the platform delivered the same promise: a complete, single-cell-resolved view of an intact adult vertebrate organ. Because zebrafish are transparent, genetically manipulable, and widely used in biomedical research, the method is likely to spread quickly through labs studying regeneration, cancer, diabetes, and congenital heart disease. The technique bridges micrometer-scale cell behaviors with centimeter-scale organ growth, closing a persistent gap in biology between what we can see in a dish and what happens in a living body. For a field that has long had to choose between seeing everything and seeing clearly, whole-organ expansion microscopy offers, for the first time, both at once.

Subject of Research: Single-cell mapping of growth dynamics and clonal organization in the developing and adult zebrafish liver

Article Title: Whole-organ single-cell mapping defines growth dynamics and clonal organization in developing and adult zebrafish livers

Article References: Roan, H.-Y., Tian, X., Chu, W.-C., Lee, C.-M., Chen, H., Santoso, F., Wang, C.-H., Liu, Y.-H., Kumar, U., Hsiao, H.-Y., Yuh, C.-H., Chen, B.-C., & Chen, C.-H. (2026). Whole-organ single-cell mapping defines growth dynamics and clonal organization in developing and adult zebrafish livers. PLOS Biology, 24(9), e3004007. https://doi.org/10.1371/journal.pbio.3004007

Image Credits: AI Generated

DOI: 10.1371/journal.pbio.3004007

Keywords: zebrafish, liver, expansion microscopy, hepatocytes, clonal expansion, organ growth, lineage tracing, extracellular matrix, laminin, single-cell imaging, PLOS Biology, regeneration

The research team enrolled 206 pediatric patients diagnosed with mycoplasma pneumoniae pneumonia and compared their peripheral blood immune and inflammatory parameters across clinically defined subgroups, distinguishing macrolide-sensitive cases from severe disease. The comparisons revealed a clear inflammatory gradient. Children with severe mycoplasma pneumonia displayed significantly elevated white blood cell counts and markedly higher circulating levels of interleukin-6, a central pro-inflammatory cytokine that drives acute-phase responses and is often used as a marker of systemic inflammation. At the same time, these severe cases showed reduced proportions of monocytes, a shift that suggests alterations in innate immune cell dynamics as the disease escalates. Taken together, these findings confirm that severe pediatric mycoplasma pneumonia is accompanied by heightened systemic inflammation, providing clinicians with measurable correlates of disease severity that go beyond symptoms and imaging.

While the blood-based immune markers painted a picture of generalized inflammation, the heart of the study lay in its analysis of the T cell receptor beta chain, specifically the complementarity-determining region 3, or CDR3. This hypervariable loop sits at the very tip of the T cell receptor and makes direct contact with peptide antigens presented by major histocompatibility complex molecules. Because the CDR3 sequence is generated through a stochastic process of V, D and J gene segment recombination, joined by random nucleotide trimming and insertion at the junctions, each naive T cell carries a essentially unique CDR3 signature. When a pathogen invades, the handful of T cells whose receptors happen to recognize its antigens undergo clonal expansion, multiplying into large populations of identical sequences that can be detected by sequencing the repertoire. The composition of these expanded clones therefore serves as a molecular record of the antigenic encounters the immune system has experienced.

To capture this record, the researchers performed TCR beta CDR3 repertoire sequencing on peripheral blood samples from eight children with mycoplasma pneumoniae pneumonia and nine age-matched healthy controls. Although the sequencing cohort was modest in size, the bioinformatic analysis was comprehensive, examining repertoire clonality, diversity indices, V and J gene segment usage, CDR3 length distributions, recombination characteristics, and the presence of disease-associated high-frequency or shared clonotypes. The results showed that children with mycoplasma pneumonia had measurably reduced CDR3 diversity compared with healthy controls, a contraction of the overall repertoire that is consistent with a strong antigen-driven response in which a limited number of pathogen-specific clones expand and crowd out the diverse background of bystander T cells.

The clonal architecture itself was also transformed. In healthy individuals, the T cell pool is dominated by a vast number of small, rare clones, with only a sparse scattering of expanded sequences. In the mycoplasma pneumonia patients, the researchers observed a shift toward more medium and large clones, indicating that a substantial fraction of the circulating T cell population had been recruited into antigen-driven expansion. This oligoclonal skewing is a hallmark of active infection and mirrors patterns previously documented in viral infections and other inflammatory lung diseases. The degree of clonal expansion, quantified through measures of clonality, could in principle serve as a quantitative readout of the intensity of the adaptive immune response, potentially helping clinicians distinguish children mounting an effective response from those at risk of immunopathology.

Beyond clonality, the study uncovered striking differences in the genetic mechanics of receptor generation. The mycoplasma pneumonia group showed significant alterations in the usage frequencies of individual TRBV and TRBJ gene segments, the variable and joining elements that form the framework of the beta chain receptor. Certain V-J pairing combinations were overrepresented or underrepresented relative to controls, suggesting that the antigenic landscape presented by mycoplasma pneumoniae selects for receptors built from particular gene segments. The patients also exhibited increased CDR3 lengths, altered amino acid composition within the hypervariable loop, and enhanced V(D)J trimming and nucleotide insertion activity at the recombination junctions. These features imply that the receptors expanded during infection tend to be longer and more compositionally distinctive than average, a pattern that may reflect the structural requirements of recognizing mycoplasma-derived peptides or, alternatively, the recruitment of T cells activated by molecular mimicry.

Perhaps the most intriguing discovery emerged from the search for pathogen-associated clonotypes. The team identified several putative mycoplasma-associated CDR3 sequences that were either present at high frequency in patients or shared across multiple individuals, suggesting convergent recognition of common mycoplasma antigens. Remarkably, some of these expanded clones showed potential cross-reactivity with respiratory viruses, including influenza and Epstein-Barr virus. This observation carries significant immunological weight. Cross-reactive T cells, activated by one pathogen but capable of recognizing structurally similar epitopes from another, are increasingly appreciated as important players in heterologous immunity, the phenomenon by which prior infections shape responses to new ones. In the context of pediatric pneumonia, such cross-reactive expansions could influence disease severity, either by accelerating viral clearance or by contributing to the immune-mediated lung damage seen in severe mycoplasma cases.

The identification of candidate immune signatures also opens a practical avenue for clinical translation. If the disease-associated clonotypes and repertoire features documented here can be validated in larger cohorts, they could form the basis of diagnostic or prognostic tools. A sequencing-based assay that detects mycoplasma-associated T cell expansions might help confirm infection in cases where culture and serology are inconclusive, since mycoplasma is notoriously difficult to grow in the laboratory and antibody responses can be delayed or unreliable in young children. Repertoire clonality measures might additionally serve as biomarkers for monitoring host immune status over the course of treatment, flagging patients whose inflammatory trajectory is worsening before clinical deterioration becomes obvious. The authors suggest that these repertoire characteristics may reflect potential biomarkers for monitoring host immune status or infection-associated T cell responses in pediatric mycoplasma pneumonia.

Several caveats temper the immediate applicability of these findings. The sequencing arm of the study included only eight patients and nine controls, a sample size sufficient for generating hypotheses but insufficient for establishing robust clinical biomarkers. Longitudinal sampling, which would track how the repertoire evolves during infection and recovery, was not performed, and the cross-reactivity assignments to influenza and Epstein-Barr virus remain putative pending functional validation with antigen-specific stimulation assays. Future studies will need to expand patient numbers, incorporate follow-up time points, and pair repertoire data with antigen-specific T cell functional testing to confirm which clonotypes genuinely recognize mycoplasma antigens and which are bystanders or cross-reactive responders.

Nevertheless, the study represents a meaningful step toward bringing immune repertoire sequencing out of the research laboratory and into pediatric infectious disease medicine. By demonstrating that mycoplasma pneumoniae leaves a detectable and characteristic imprint on the TCR beta CDR3 landscape of infected children, the work establishes a framework for understanding the immunological heterogeneity that underlies the variable clinical course of this common infection. As sequencing costs continue to fall and analytical pipelines mature, the kind of repertoire profiling demonstrated here could eventually complement conventional laboratory tests, giving clinicians a dynamic view of the adaptive immune response as it unfolds. For a pathogen that has repeatedly proven difficult to detect and even more difficult to anticipate in terms of severity, the T cell receptor repertoire may prove to be one of the most informative windows yet into how the body fights back.

Subject of Research: T cell receptor repertoire changes in pediatric Mycoplasma pneumoniae pneumonia

Article Title: TCR β CDR3 repertoire profiling identifies pathogen-associated clonal expansions and candidate immune signatures in pediatric Mycoplasma pneumoniae pneumonia

Article References: Yuan, Y., Hui, L., Zhang, X., Liu, X., Yang, C., Xu, Y., Yao, X., Chen, Y., & Li, J. (2026). TCR β CDR3 repertoire profiling identifies pathogen-associated clonal expansions and candidate immune signatures in pediatric Mycoplasma pneumoniae pneumonia. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-08992-4

Image Credits: AI Generated

DOI: 10.1186/s12967-026-08992-4

Keywords: Mycoplasma pneumoniae, pediatric pneumonia, TCR repertoire, CDR3 diversity, high-throughput sequencing, T cell receptor, clonal expansion, interleukin-6, immune biomarkers, cross-reactivity, macrolide resistance, Journal of Translational Medicine

The study, led by Zhe Ying, Assistant Professor of Stem Cell Biology and Regenerative Medicine at Mount Sinai, with postdoctoral fellow Qiwen Gan and coauthors including researchers from the Fred Hutchinson Cancer Center in Seattle, focused on a question that has lingered in the field for years. Scientists have long understood that p53 loss does not simply remove a block to proliferation. Something about the behavior of the tissue itself changes when p53-deficient cells begin to spread. What that something was, and how it operated across a population of cells rather than within a single cell, remained unclear. The Mount Sinai team suspected the answer lay not in the raw quantity of growth signals but in their geometry.

Using mouse skin as their experimental model, the researchers tracked how groups of p53-deficient epithelial cells, known as clones, expanded within otherwise normal tissue over time. This longitudinal view revealed something unexpected about the engine driving clonal expansion. It was not faster cell division, and it was not reduced cell death. Instead, the decisive shift was in cell fate. Mutant progenitor cells became more likely to remain self-renewing, perpetually replenishing their own population, and less likely to differentiate into mature, specialized cells that would eventually be shed. This fate bias gave the mutant clones a slow but relentless demographic advantage, allowing them to keep expanding through the surrounding normal epithelium one cell fate decision at a time.

To trace the mechanism behind this behavior, the team assembled an unusually comprehensive set of tools. They performed gene-expression analysis to see which programs were active in the mutant cells, mapped where p53 binds to DNA to identify its direct targets, and carried out a genetic screen of more than 1,000 candidate p53-regulated genes. They then imaged Wnt signaling, a major pathway that controls tissue growth and development, at the level of single cells. This combination allowed them to connect the dots between p53 loss, the behavior of specific genes, and the spatial pattern of signaling across an entire clone. Three genes emerged as critical intermediaries: Sfrp1, Lrp1, and Usp22, each of which is directly regulated by p53 and each of which normally helps restrain Wnt signaling.

When p53 was lost, these restraints came off. Wnt activity rose, but crucially, it did not rise uniformly. Instead, it became organized into a persistent radial gradient, with lower Wnt activity near the edge of the mutant clone and higher activity toward its center. This spatial arrangement proved to be the real driver of expansion. Clones carrying the gradient expanded efficiently through normal tissue, while clones in which Wnt activity was elevated more evenly across the population expanded less effectively, even when their overall Wnt activity was higher than that of the gradient-bearing clones. The finding upends a common assumption in the field: what matters is not simply how much Wnt signaling is present, but how that signal is distributed in space.

The researchers then put this interpretation to a direct experimental test. By artificially altering the spatial pattern of Wnt activity, they asked whether clonal expansion depended primarily on the total amount of signaling or on its organization across the mutant cell population. The results were unambiguous. Disrupting the Wnt gradient sharply limited the ability of p53-deficient cells to overcome their normal neighbors, even when Wnt signaling itself remained active. The gradient, in other words, is not a byproduct of expansion but a functional requirement for it, a structural feature of the mutant population that normal tissue containment strategies apparently cannot counter.

The implications of this spatial principle extend well beyond skin. Most tissues in aging bodies carry cells with cancer-associated mutations that remain contained, a phenomenon documented across the gut, esophagus, skin, and other epithelia. Understanding why some of these mutant populations break out while most never do is one of the central questions in early cancer development. This study provides a concrete mechanism: loss of a single tumor suppressor can reshape the signaling landscape of an entire clone, converting a contained population into one with the organizational capacity to invade. It suggests that the transition from harmless mutant cell to expanding clone may be detectable, and perhaps targetable, at the level of tissue organization long before any overt tumor forms.

Senior author Dr. Ying summarized the conceptual shift in a statement accompanying the release: “Our study found that it is not simply how much Wnt signaling is present that matters, but how that signal is organized across a population of mutant cells. When p53 is lost, Wnt activity becomes organized into a persistent spatial gradient that helps progenitor cells maintain self-renewal and allows the mutant population to continue expanding through otherwise normal tissue.” The quote captures what may be the study’s most lasting contribution, a framework in which the spatial arrangement of signaling pathways is treated as an independent and potentially decisive variable in cancer initiation, on par with pathway activation itself.

The work also reframes the role of p53 in a way that may influence how researchers think about tumor suppression more broadly. Rather than acting solely as a cell-intrinsic guardian that halts damaged cells from dividing, p53 appears to function as an architect of tissue-level signaling order, indirectly maintaining the spatial constraints that keep mutant populations in check. Its three identified targets, Sfrp1, Lrp1, and Usp22, now stand as candidate points of intervention, since restoring their restraining influence on Wnt organization could in principle recontain expanding clones. The research was supported by funding from the National Cancer Institute, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Dental and Craniofacial Research, the Department of Defense, and the American Cancer Society, reflecting the breadth of interest in how early mutant expansion might one day be intercepted before it becomes disease.

Subject of Research: How p53 loss reorganizes Wnt signaling gradients to drive epithelial clonal expansion in tissue

Article Title: Mount Sinai study uncovers how loss of the critical tumor suppressor p53 enables mutant cells to expand through normal tissue

Article References: Mount Sinai study uncovers how loss of the critical tumor suppressor p53 enables mutant cells to expand through normal tissue. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: p53, tumor suppressor, Wnt signaling, clonal expansion, epithelial tissue, stem cells, self-renewal, cell differentiation, cancer initiation, spatial signaling gradient, mouse skin model, Mount Sinai

The mitochondrial genome occupies a peculiar position among the body’s genetic material. Unlike the two copies of each nuclear chromosome, mitochondria carry hundreds to thousands of copies of their own compact genome per cell, encoding thirteen proteins of the oxidative phosphorylation machinery along with the RNA molecules needed to build them. Because this multi-copy system complements defective genomes with functional ones, a newly arising mutation is initially diluted to near-undetectable levels and produces no biochemical consequence. The biologically relevant quantity, the review emphasizes, is not the tissue average but the per-cell distribution, and in particular the fraction of cells in which a mutant clone has crossed the functional threshold for that particular mutation. This threshold behavior explains a long-standing paradox: bulk measurements of heteroplasmy, the coexistence of mutant and wild-type mitochondrial genomes, often appear too low to matter, even though individual cells can be nearly homoplasmic for a damaging variant and frankly respiratory-deficient.

Two mechanistically distinct classes of somatic lesion drive the clock, and they behave differently. Point mutations, dominated by a G-to-A mutational signature indicative of replication errors rather than oxidative damage, accumulate across essentially all tissues and constitute the bulk of the cryptic, cell-unique burden. Large-scale deletions are rarer at the molecular level but expand with particular efficiency in long-lived post-mitotic cells such as skeletal muscle fibers and the dopaminergic neurons of the substantia nigra, where a single deleted species can come to dominate a cell and abolish respiration. Classic studies showed that these neurons accumulate high deletion loads during normal aging, with deletion burden significantly higher in respiratory-deficient neurons than in healthy ones. In muscle, decades of debate about how deletions expand have been resolved by models of density-dependent stochastic survival that require no replicative advantage at all, while droplet digital PCR has linked clonal deletion load directly to focal respiratory failure, fiber by fiber.

Proliferative tissues convert the same mutational process into a visible clonal history. The human colonic crypt is maintained by a handful of basal stem cells whose descendants migrate upward, so a mutation fixed in a stem cell is propagated through the entire crypt. Comprehensive analysis of aging colorectal epithelium showed that clonally expanded point mutations arise from early to mid-life and drive a substantial burden of respiratory-chain dysfunction by old age. Because adjacent respiratory-deficient cells are clonally derived, naturally occurring mitochondrial mutations act as endogenous lineage labels, and their distribution has even been used to quantify human intestinal stem-cell numbers and crypt fission dynamics. The convergence of proliferative and post-mitotic tissues on the same outcome, age-dependent, clonal, threshold-limited respiratory deficiency, forms the empirical core of the mitochondrial clock concept.

Causality, long contested, was decisively addressed by the mitochondrial mutator mouse, which expresses a proofreading-deficient polymerase and accumulates a markedly increased mutation load, developing a premature-aging phenotype. Independent lines confirmed that mutation accumulation drives apoptosis in aging tissues, and heterozygous models that accumulate clonally expanded point mutations without gross structural instability reproduce a respiratory-deficiency phenotype closely paralleling aged human colon. A multi-tissue duplex-sequencing survey cataloged more than 89,000 independent somatic mitochondrial mutations in aging mice, revealing tissue-specific accumulation rates that did not track mitochondrial content and confirming that the dominant aging signature reflects replication errors rather than reactive oxygen species, a finding with sobering implications for antioxidant-based anti-aging strategies.

How clonal expansion actually proceeds remains an active frontier. Because mitochondrial DNA turns over continuously and is randomly partitioned, any variant’s frequency performs a random walk, and some drift toward fixation by chance even in non-dividing cells. Recent single-cell work, combining precise mitochondrial base editing with ultra-high-throughput heteroplasmy tracking, showed that in dividing cells selection rather than simple drift shapes population heteroplasmy, with the direction of selection on a given variant depending wholly on the cellular environment. Single-cell multi-omic profiling of human immune cells carrying pathogenic variants revealed dynamic purifying selection that varies across cell types. The contemporary synthesis is that drift and selection operate in different tissues and contexts, and that many apparent somatic variants are pre-existing heteroplasmies carried as passengers during clonal expansion.

The clock, it turns out, is not a single dial but several. Multi-tissue profiling across dozens of human tissues from hundreds of individuals revealed that mitochondrial clonal mosaicism develops with two distinct, tissue-dependent aging signatures. In proliferative tissues with constant turnover, aging is marked by accelerated accumulation of sporadic mutations and their clonal expansion, with implications for tumorigenesis, since pan-cancer data show that truncating mitochondrial mutations are positively selected in kidney, colorectal, and thyroid cancers. In post-mitotic, high-energy tissues such as heart and brain, mutations accumulate preferentially at deterministic, recurrently mutated hotspots. Any practical biological-age estimator built on heteroplasmy would therefore need separate, tissue-specific calibration, combining a point-mutation term for blood and renewing epithelia with a deletion term for muscle and brain, an integration the authors explicitly flag as an open calibration problem rather than a solved feature.

Population-scale evidence has moved heteroplasmy from tissue-biology curiosity to clinical trait. Sequencing across roughly 300,000 individuals showed that heteroplasmic variants accumulate sharply after about age seventy and that clock rate is itself partly heritable under nuclear genetic control. In nearly 195,000 UK Biobank participants, heteroplasmy was associated with an approximately 1.5-fold increased risk of all-cause mortality, along with cancer incidence and cancer-specific mortality. A 2025 analysis of more than 369,000 participants linked accumulated heteroplasmic mutations to chronic kidney disease severity and acute kidney injury through suppressed purine metabolism amenable to metabolic rescue. A two-step mechanism, drawn from genome-wide analysis of blood in roughly 750,000 people, ties the picture together: cells first acquire low-level cryptic mutations, which then become detectable when the clones carrying them proliferate, unifying somatic mitochondrial accumulation with clonal hematopoiesis and explaining why the clock appears to accelerate in late life.

Can the clock be slowed? The review maps three classes of intervention. Caloric restriction slows cryptic mutation accumulation across single cells, and exercise improves mitochondrial capacity in aging muscle. The mitophagy activator urolithin A has improved muscle strength and endurance in randomized trials in middle-aged and older adults and enhanced cardiac mitochondrial quality in preclinical and human studies, potentially biasing the surviving mitochondrial pool toward functional genomes even without lowering the mutation rate. Most ambitiously, CRISPR-free mitochondrial base editors and TALE-linked deaminases now allow programmable editing of the mitochondrial genome in principle, making the intracellular mitochondrial population a manipulable substrate, though delivery and off-target concerns keep such approaches at proof-of-concept for somatic aging. Positioned alongside epigenetic methylation clocks, the mitochondrial clock offers something orthogonal: a high-copy, single-cell-traceable genome whose damage is mechanistically tied to bioenergetic failure, inflammaging through cGAS-STING signaling, senescence, and hard clinical outcomes. The authors argue that the path forward lies less in discovering new phenomena than in the unglamorous work of calibration, standardization, and longitudinal validation that could turn a compelling biological signal into a dependable, blood-readable instrument for measuring how fast an individual is aging.

Subject of Research: Clonal mosaicism of mitochondrial DNA heteroplasmy as a tissue-specific molecular clock of biological aging.

Article Title: Clonal Mosaicism of Mitochondrial DNA Heteroplasmy as a Molecular Clock of Aging

Article References: Chang, R., Tsai, A. P., Wang, B., Tsui, K.-H., Pang, C.-Y., & Li, C.-J. (2026). Clonal Mosaicism of Mitochondrial DNA Heteroplasmy as a Molecular Clock of Aging. Aging Cell, 25(9), Article e70718. https://doi.org/10.1111/acel.70718

Image Credits: AI Generated

DOI: 10.1111/acel.70718

Keywords: mitochondrial DNA, heteroplasmy, clonal mosaicism, molecular clock, aging, somatic mutations, clonal expansion, mitophagy, inflammaging, biological age, single-cell sequencing, mtDNA deletions